Low-dose Rituximab Monotherapy or in Combination with Tacrolimus Is Effective in Primary Membranous Nephropathy

被引：3
|
作者：
Pathak, Vivek [1 ]
Venkatesan, Madhav [1 ]
Regunathan-Shenk, Renu [1 ,2 ]
机构：
[1] Kovai Med Ctr & Hosp, Nephrol, Coimbatore 641014, Tamil Nadu, India
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
来源：
KIDNEY360 | 2021年 / 2卷 / 02期
关键词：
clinical nephrology; cyclosporine; membranous glomerulonephritis; remission induction; rituximab; tacrolimus;
D O I：
10.34067/KID.0004672020
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：336 / 338
页数：3
相关论文
共 50 条
  • [41] TACROLIMUS PLUS LOW DOSE PREDNISOLONE THERAPY IS MORE EFFECTIVE IN PLA2R-VE MEMBRANOUS NEPHROPATHY PATIENTS
    Jaiswal, Akhilesh Kumar
    Prasad, Narayan
    Agarwal, Vikas
    Singh, Mantabya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 710 - 710
  • [42] Administration of low-dose cyclosporine alone for the treatment of elderly patients with membranous nephropathy
    Li, M. X.
    Yu, Y. W.
    Zhang, Z. Y.
    Zhao, H. D.
    Xiao, F. L.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (01) : 2665 - 2673
  • [43] Efficacy and Safety of Low-Dose Chlorambucil in Nephrotic Patients with Idiopathic Membranous Nephropathy
    Idasiak-Piechocka, Ilona
    Oko, Andrzej
    Lochynska-Bielecka, Katarzyna
    Skrobanska, Beata
    KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (04): : 263 - 267
  • [44] A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Tassiulas, IO
    Boumpas, DT
    Vaughan, E
    Fleisher, TA
    Piscetelli, S
    Kim, Y
    Puccino, F
    Balow, JE
    Austin, HA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A2679 - A2679
  • [45] Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China
    Zeng, Li
    Chen, Huihui
    Xiang, Heng
    Zeng, Mengru
    Zhou, Mi
    Tan, Chongqing
    Liu, Hong
    Chen, Guochun
    FRONTIERS IN PHARMACOLOGY, 2024, 14
  • [46] Obinutuzumab is effective for the treatment of rituximab-resistant membranous nephropathy
    Lu, Wanhong
    Li, Huixian
    Jin, L., I
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [47] Obinutuzumab is effective for the treatment of rituximab-resistant membranous nephropathy
    Lu, Wanhong
    Li, Huixian
    Jin, Li
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I632 - I632
  • [48] Tacrolimus in resistant primary membranous nephropathy - a report of 3 cases
    Szeto, CC
    Leung, CB
    Lai, FMM
    Li, PKT
    CLINICAL NEPHROLOGY, 2003, 59 (04) : 293 - 296
  • [49] Low-dose rituximab in adult patients with primary immune thrombocytopenia
    Zaja, Francesco
    Vianelli, Nicola
    Volpetti, Stefano
    Battista, Marta Lisa
    Defina, Marzia
    Palmieri, Salvatore
    Bocchia, Monica
    Medeot, Marta
    De Luca, Stefano
    Ferrara, Felicetto
    Isola, Miriam
    Baccarani, Michele
    Fanin, Renato
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2010, 85 (04) : 329 - 334
  • [50] Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?
    Mirioglu, Safak
    Akyildiz, Arif
    Ucar, Ali Riza
    Uludag, Omer
    Ozluk, Yasemin
    Dirim, Ahmet Burak
    Demir, Erol
    Oto, Ozgur Akin
    Kilicaslan, Isin
    Caliskan, Yasar
    Yazici, Halil
    Turkmen, Aydin
    Sever, Mehmet Sukru
    TURKISH JOURNAL OF NEPHROLOGY, 2023, 32 (03): : 209 - +
12345